IMDX vs XOM · rev $271.0K vs P/E 24, rev $201.16B
Insight Molecular Diagnostics Inc. (IMDX) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Insight Molecular Diagnostics Inc. (IMDX) is a diagnostics & research company listed on US.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren Woods.
Latest reported IMDX revenue for 2026-06-30 was $271.0K. Net income was -$15.6M. IMDX currently screens at market cap $0.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
IMDX currently screens at market cap $0. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the IMDX and XOM stock pages for the full models.
Not investment advice.